2025
Incidence of Dysphagia and Comorbidities in Patients with Cervical Dystonia, Analyzed by Botulinum Neurotoxin Treatment Exposure
Barbano R, Jabbari B, Sadeghi M, Ukah A, Yue E, Ifantides K, Huang N, Swope D. Incidence of Dysphagia and Comorbidities in Patients with Cervical Dystonia, Analyzed by Botulinum Neurotoxin Treatment Exposure. Toxins 2025, 17: 148. PMID: 40137921, PMCID: PMC11945862, DOI: 10.3390/toxins17030148.Peer-Reviewed Original ResearchConceptsIncidence of dysphagiaCervical dystoniaComorbid conditionsContinuous health plan enrollmentCohort entry dateRate of dysphagiaRetrospective cohort studyPre-existing dysphagiaHealth plan enrollmentRisk factors of dysphagiaFactors of dysphagiaReal-world studyPotential adverse eventsPotential risk factorsPatient-level dataReal-world analysisAdverse eventsCD patientsCohort studyComorbid neurological conditionsLongitudinal patient-level dataCD diagnosisDysphagiaDysphagia riskPatients
2017
RimabotulinumtoxinB in sialorrhea: systematic review of clinical trials
Dashtipour K, Bhidayasiri R, Chen JJ, Jabbari B, Lew M, Torres-Russotto D. RimabotulinumtoxinB in sialorrhea: systematic review of clinical trials. Journal Of Clinical Movement Disorders 2017, 4: 9. PMID: 28593050, PMCID: PMC5460542, DOI: 10.1186/s40734-017-0055-1.Peer-Reviewed Original ResearchAdverse eventsClinical trialsSystematic reviewDose-dependent adverse eventsMethodsA systematic literature reviewMild transient dysphagiaMost adverse eventsComparative clinical studyTreatment of patientsMedical literature databasesDry mouthTransient dysphagiaMild weaknessClinical studiesToxin effectsLiterature databasesBoNTIndividual studiesTrialsTreatmentPrimary publicationsDosesSystematic literature reviewSignificant benefitsReview
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply